Both in Pharmaceuticals
Shattuck Labs vs Ovid Therapeutics
Over the past year STTK returned +166.8% and OVID returned +106.0%; their daily moves had a correlation of 0.30.
STTK +166.8% OVID +106.0%Growth of $1, one year, split-adjusted
| Metric | STTK | OVID |
|---|---|---|
| Price | $5.15 | $2.74 |
| Market cap | $516.9M | $535.1M |
| Today | −5.85% | +14.17% |
| 1 month | −12.1% | +15.6% |
| 6 months | −22.9% | −1.4% |
| Year to date | +41.1% | +68.1% |
| 1 year | +158.8% | +98.6% |
| Revenue growth (YoY) | — | −88.3% |
| Gross margin | — | 100.0% |
| Net margin | — | −2047.6% |
| P/E (TTM) | — | — |
| Price / sales | 516.9× | 338.0× |
| Net cash | $208.3M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 59.6% | 64.9% |
| Short % of float | 13.2% | 10.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).